188 related articles for article (PubMed ID: 25919064)
21. Childhood psoriasis.
Dogra S; Kaur I
Indian J Dermatol Venereol Leprol; 2010; 76(4):357-65. PubMed ID: 20657115
[TBL] [Abstract][Full Text] [Related]
22. Psoriasis and psoriatic arthritis: immunological aspects and therapeutic guidelines.
Griffiths CE; Iaccarino L; Naldi L; Olivieri I; Pipitone N; Salvarani C; Doria A
Clin Exp Rheumatol; 2006; 24(1 Suppl 40):S72-8. PubMed ID: 16466629
[TBL] [Abstract][Full Text] [Related]
23. Emerging topical treatments for psoriasis.
Kivelevitch DN; Hebeler KR; Patel M; Menter A
Expert Opin Emerg Drugs; 2013 Dec; 18(4):523-32. PubMed ID: 24274614
[TBL] [Abstract][Full Text] [Related]
24. Analysis of psoriatic patients registered in Asahikawa Medical College Hospital from 1983 to 2007.
Takahashi H; Takahashi I; Tsuji H; Ibe M; Kinouchi M; Hashimoto Y; Ishida-Yamamoto A; Matsuo S; Ohkuma N; Ohkawara A; Iizuka H
J Dermatol; 2009 Dec; 36(12):632-7. PubMed ID: 19958446
[TBL] [Abstract][Full Text] [Related]
25. Nanocarriers for the topical treatment of psoriasis - pathophysiology, conventional treatments, nanotechnology, regulatory and toxicology.
Mascarenhas-Melo F; Carvalho A; Gonçalves MBS; Paiva-Santos AC; Veiga F
Eur J Pharm Biopharm; 2022 Jul; 176():95-107. PubMed ID: 35605927
[TBL] [Abstract][Full Text] [Related]
26. Differential diagnosis of psoriasis.
Lisi P
Reumatismo; 2007; 59 Suppl 1():56-60. PubMed ID: 17828346
[TBL] [Abstract][Full Text] [Related]
27. Pustular psoriasis and the Kobner phenomenon caused by allergic contact dermatitis from zinc pyrithione-containing shampoo.
Jo JH; Jang HS; Ko HC; Kim MB; Oh CK; Kwon YW; Kwon KS
Contact Dermatitis; 2005 Mar; 52(3):142-4. PubMed ID: 15811028
[TBL] [Abstract][Full Text] [Related]
28. [Severe initial manifestations of psoriasis in staphylococcal infections].
Tunus G; Pilger U; Aberer E
Wien Klin Wochenschr; 2001 Oct; 113(19):747-51. PubMed ID: 11715754
[TBL] [Abstract][Full Text] [Related]
29. The role of vitamin D in psoriasis: a review.
Soleymani T; Hung T; Soung J
Int J Dermatol; 2015 Apr; 54(4):383-92. PubMed ID: 25601579
[TBL] [Abstract][Full Text] [Related]
30. TNF-α in a molecularly targeted therapy of psoriasis and psoriatic arthritis.
Wcisło-Dziadecka D; Zbiciak-Nylec M; Brzezińska-Wcisło L; Mazurek U
Postgrad Med J; 2016 Mar; 92(1085):172-8. PubMed ID: 26719452
[TBL] [Abstract][Full Text] [Related]
31. Emerging oral drugs for psoriasis.
Mahmood T; Zaghi D; Menter A
Expert Opin Emerg Drugs; 2015 Jun; 20(2):209-20. PubMed ID: 25643592
[TBL] [Abstract][Full Text] [Related]
32. Infliximab in psoriasis and psoriatic arthritis.
Papoutsaki M; Osório F; Morais P; Torres T; Magina S; Chimenti S; Costanzo A
BioDrugs; 2013 Jan; 27 Suppl 1():13-23. PubMed ID: 23990278
[TBL] [Abstract][Full Text] [Related]
33. Pustular and erythrodermic psoriasis.
Prystowsky JH; Cohen PR
Dermatol Clin; 1995 Oct; 13(4):757-70. PubMed ID: 8785881
[TBL] [Abstract][Full Text] [Related]
34. Nanodermatology-based solutions for psoriasis: State-of-the art and future prospects.
Damiani G; Pacifico A; Linder DM; Pigatto PDM; Conic R; Grada A; Bragazzi NL
Dermatol Ther; 2019 Nov; 32(6):e13113. PubMed ID: 31600849
[TBL] [Abstract][Full Text] [Related]
35. Transdermal Delivery of Therapeutic Compounds With Nanotechnological Approaches in Psoriasis.
Li N; Qin Y; Dai D; Wang P; Shi M; Gao J; Yang J; Xiao W; Song P; Xu R
Front Bioeng Biotechnol; 2021; 9():804415. PubMed ID: 35141215
[TBL] [Abstract][Full Text] [Related]
36. Dapsone Therapy for Pustular Psoriasis: Case Series and Review of the Literature.
Sheu JS; Divito SJ; Enamandram M; Merola JF
Dermatology; 2016; 232(1):97-101. PubMed ID: 26465742
[TBL] [Abstract][Full Text] [Related]
37. New biologics for psoriasis and psoriatic arthritis.
Rozenblit M; Lebwohl M
Dermatol Ther; 2009; 22(1):56-60. PubMed ID: 19222517
[TBL] [Abstract][Full Text] [Related]
38. [Kawasaki's disease with eruptive pustular and guttate psoriasis].
Boralevi F; Barat P; Lepreux S; Stockman AL; Taïeb A; Léauté-Labrèze C
Ann Dermatol Venereol; 2003 May; 130(5):528-31. PubMed ID: 12843830
[TBL] [Abstract][Full Text] [Related]
39. Childhood psoriasis.
Farber EM; Nall L
Cutis; 1999 Nov; 64(5):309-14. PubMed ID: 10582153
[TBL] [Abstract][Full Text] [Related]
40. Recent Advancement in Topical Drug Delivery for Psoriasis: Clinical Pertinence and Potential Market.
Kumari R; Halder J; Sharma A; Rai VK
Curr Drug Targets; 2021; 22(13):1507-1523. PubMed ID: 33845737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
